Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
P/S ratio for Agios Pharmaceuticals (AGIO)
P/S ratio as of May 2024 (TTM): 74.1
According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 74.0803. At the end of 2023 the company had a P/S ratio of 46.4.
P/S ratio history for Agios Pharmaceuticals from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 46.4 | -57.17% |
| 2022 | 108 | |
| 2021 | N/A | -100% |
| 2020 | 68.1 | 145.98% |
| 2019 | 27.7 | -2.61% |
| 2018 | 28.4 | -56.11% |
| 2017 | 64.8 | 158.33% |
| 2016 | 25.1 | -39.4% |
| 2015 | 41.4 | -34.91% |
| 2014 | 63.6 | 117.43% |
| 2013 | 29.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.80 | -96.22% | 🇺🇸 USA |
 Eli Lilly LLY | 20.4 | -72.47% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.40 | -96.76% | 🇬🇧 UK |
 Xencor XNCR | 8.23 | -88.89% | 🇺🇸 USA |
 Exelixis EXEL | 3.35 | -95.48% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 5.91 | -92.02% | 🇺🇸 USA |